Dalia Bracha

Dalia Bracha has worked in the pharmaceutical industry since 2001. Dalia began their career as a Senior CRA at Eli-Lilly Israel in 2001. Dalia then moved to Johnson & Johnson PRD in 2004, where they held the roles of Local Trial Manager, Functional Manager and Training Manager. In 2008, they became a Clinical Research Manager at Gamida Cell Ltd. and in 2011, they took on the role of Clinical Operations Lead at Pfizer. In 2016, they became the Regional Clinical Site Lead (RCSL) at Pfizer, responsible for in-country site management and oversight activities, providing local input to country strategy, feasibility and protocol design, and responsible for site selection coordination at country level. That same year, they also founded D.B. Clinical Trials, where they served as CEO. In 2019, they became Project Director at BioSight Ltd. and in 2020, they took on the role of Senior Clinical Project Manager at Karyopharm Therapeutics Inc. Most recently, they are the Head of Clinical Project Management and Operations at ImmunoBrain Checkpoint.

Dalia Bracha completed a Certified NLP Practitioner program at Karkur College in 2020. Prior to that, they obtained an MPA from Clark University in 1998 and a BA in Nursing from Tel Aviv University in 1995.